Guizhou Weilan Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Guizhou Weilan Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include PHEAYAL. The owner is based in Yunyan Dist., Guiyang.

No.1,10/F, Unit 1, Building 30, Future

Ark G1 Group, Shuidong Rd Street,

Yunyan Dist., Guiyang 550000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PHEAYAL
PHEAYAL
Registered 2022

Trademark Classifications

Guizhou Weilan Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Guizhou Weilan Technology Co., Ltd. have?

Guizhou Weilan Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Guizhou Weilan Technology Co., Ltd. file in?

Guizhou Weilan Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Guizhou Weilan Technology Co., Ltd.'s most well-known trademarks?

Guizhou Weilan Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as PHEAYAL. These are among 1 currently registered trademark in the portfolio.

What is Guizhou Weilan Technology Co., Ltd.'s trademark registration success rate?

Guizhou Weilan Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.